These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29473173)

  • 81. Prevention of HLA alloimmunization: role of leukocyte depletion and UV-B irradiation.
    Snyder EL
    Yale J Biol Med; 1990; 63(5):419-27. PubMed ID: 2293501
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Incidence of transfusion-induced platelet-reactive antibodies evaluated by specific assays for the detection of human leucocyte antigen and human platelet antigen antibodies.
    Fontão-Wendel R; Silva LC; Saviolo CB; Primavera B; Wendel S
    Vox Sang; 2007 Oct; 93(3):241-9. PubMed ID: 17845262
    [TBL] [Abstract][Full Text] [Related]  

  • 83. HLA alloimmunization against platelet transfusions: pathophysiology, significance, prevention and management.
    Pavenski K; Freedman J; Semple JW
    Tissue Antigens; 2012 Apr; 79(4):237-45. PubMed ID: 22385314
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A prospective, active haemovigilance study with combined cohort analysis of 19,175 transfusions of platelet components prepared with amotosalen-UVA photochemical treatment.
    Knutson F; Osselaer J; Pierelli L; Lozano M; Cid J; Tardivel R; Garraud O; Hervig T; Domanovic D; Cukjati M; Gudmundson S; Hjalmarsdottir IB; Castrillo A; Gonzalez R; Brihante D; Santos M; Schlenke P; Elliott A; Lin JS; Tappe D; Stassinopoulos A; Green J; Corash L
    Vox Sang; 2015 Nov; 109(4):343-52. PubMed ID: 25981525
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Transfusion-induced bone marrow transplant rejection due to minor histocompatibility antigens.
    Patel SR; Zimring JC
    Transfus Med Rev; 2013 Oct; 27(4):241-8. PubMed ID: 24090731
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Persistence of lymphocytotoxic antibodies in patients in the trial to reduce alloimmunization to platelets: implications for using modified blood products.
    Slichter SJ; Bolgiano D; Kao KJ; Kickler TS; McFarland J; McCullough J; Woodson R
    Transfus Med Rev; 2011 Apr; 25(2):102-10. PubMed ID: 21345638
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Extreme leukoreduction of major histocompatibility complex class II positive B cells enhances allogeneic platelet immunity.
    Semple JW; Speck ER; Cosgrave D; Lazarus AH; Blanchette VS; Freedman J
    Blood; 1999 Jan; 93(2):713-20. PubMed ID: 9885234
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Platelet-specific antibodies in HLA-immunized patients receiving chronic platelet support.
    Sanz C; Freire C; Alcorta I; Ordinas A; Pereira A
    Transfusion; 2001 Jun; 41(6):762-5. PubMed ID: 11399816
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Dominant immune response to HLA-B57/B58 molecules after platelet transfusion.
    Coombs J; Ben Hassen L; Leclerc M; Tamagne M; Pannetier L; Khelfa M; Delorme A; Bocquet T; Maury S; Pirenne F; Ansart-Pirenne H; Vingert B
    Transfusion; 2020 Dec; 60(12):2807-2814. PubMed ID: 33037638
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Use of 8-methoxypsoralen and ultraviolet-A pretreated platelet concentrates to prevent alloimmunization against class I major histocompatibility antigens.
    Grana NH; Kao KJ
    Blood; 1991 Jun; 77(11):2530-7. PubMed ID: 1828180
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Platelet component transfusion and alloimmunization: Where do we stand?
    Moncharmont P
    Transfus Clin Biol; 2018 Sep; 25(3):172-178. PubMed ID: 29478960
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The treatment of blood components with ultraviolet-B irradiation.
    Pamphilon DH
    Vox Sang; 1998; 74 Suppl 2():15-9. PubMed ID: 9704422
    [No Abstract]   [Full Text] [Related]  

  • 93. Use of single donor platelets.
    Kirkley SA; Blumberg N
    Blood Rev; 1994 Sep; 8(3):142-7. PubMed ID: 7819816
    [TBL] [Abstract][Full Text] [Related]  

  • 94. INTERCEPT pathogen-reduced platelets are not associated with higher rates of alloimmunization with (or without) clinical refractoriness in published studies.
    Benjamin RJ; Corash L; Norris PJ
    Transfusion; 2020 Apr; 60(4):881-882. PubMed ID: 32246477
    [No Abstract]   [Full Text] [Related]  

  • 95. Transfusion-related immunomodulation: gamma irradiation alters the effects of leukoreduction on alloimmunization.
    Nelson KA; Aldea GS; Warner P; Latchman Y; Gunasekera D; Tamir A; Gernsheimer T; Bolgiano D; Slichter SJ
    Transfusion; 2019 Nov; 59(11):3396-3404. PubMed ID: 31608454
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Leukocyte depletion of blood products and anti-HLA immunization].
    Valla A
    Rev Fr Transfus Hemobiol; 1993 Jun; 36(3):281-91. PubMed ID: 8347251
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Comparative study of alloimmune reactions induced by leukocyte and platelet transfusions in humans: characteristic changes of activation markers, gamma interferon, and FcR blocking antibody production.
    Kotlán B; Gyódi E; Szabó T; Takács K; Troppmair J; Petri I; Padányi A; Kaiser G; Kassai M; Huber C
    Hum Immunol; 1988 May; 22(1):19-29. PubMed ID: 3134315
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Systematic use of leukocyte-free blood components to prevent alloimmunization and platelet refractoriness in multitransfused children with cancer.
    Saarinen UM; Koskimies S; Myllylä G
    Vox Sang; 1993; 65(4):286-92. PubMed ID: 8310680
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Pathogen reduction with amotosalen/UVA reduces platelet refractoriness in a dog platelet transfusion model.
    Slichter SJ; Bailey SL; Gettinger I; Pellham E; Christoffel T; Castro G; Green JM; Stassinopoulos A
    Vox Sang; 2019 Aug; 114(6):595-604. PubMed ID: 31297836
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Effective prophylaxis against platelet refractoriness in multitransfused patients by use of leukocyte-free blood components.
    Saarinen UM; Kekomäki R; Siimes MA; Myllylä G
    Blood; 1990 Jan; 75(2):512-7. PubMed ID: 2295005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.